MiR-515-5p通过调控硫酸软骨素蛋白聚糖4表达对卵巢癌A2780细胞增殖和转移的影响及其机制

江红 黄艳丽 邢辉 汪黎明 郭红

解剖学报 ›› 2022, Vol. 53 ›› Issue (1) : 42-49.

PDF(11747 KB)
欢迎访问《解剖学报》官方网站!今天是 English
PDF(11747 KB)
解剖学报 ›› 2022, Vol. 53 ›› Issue (1) : 42-49. DOI: 10.16098/j.issn.0529-1356.2022.01.006

MiR-515-5p通过调控硫酸软骨素蛋白聚糖4表达对卵巢癌A2780细胞增殖和转移的影响及其机制

  • 江红1 黄艳丽1 邢辉1 汪黎明2 郭红1*
作者信息 +

Effects of miR-515-5p on the proliferation and metastasis of ovarian cancer cell A2780 by regulating the expression of chondroitin sulfate proteoglycan 4 and its mechanism

  • JIANG Hong1  HUANG Yan-li XING Hui1  WANG Li-ming2  GUO Hong1*
Author information +
文章历史 +

摘要

目的  探讨miR-515-5p对硫酸软骨素蛋白聚糖4(CSPG4)的靶向调控作用,以及对卵巢癌细胞系A2780细胞增殖和转移的影响。   方法  通过生物信息学工具预测miR-515-5p的靶基因。Real-time PCR和Western blotting法检测65例卵巢癌组织和与其对应的癌旁组织中miR-515-5p和CSPG4的表达。将A2780细胞分为miR-NC组、miR-515-5p组、si-NC组、si-CSPG4组、miR-515-5p+pcDNA组和miR-515-5p+pcDNA-CSPG4组。MTT法检测细胞增殖活力,Transwell检测细胞迁移和侵袭数,Western blotting检测细胞周期蛋白D1(cyclinD1)、P21、基质金属蛋白酶(MMP)-2和MMP-9蛋白的表达。双荧光素酶报告基因实验和Western blotting验证miR-515-5p对CSPG4基因的调控作用。   结果  生物信息学分析显示,CSPG4是miR-515-5p的潜在靶基因之一。与癌旁组织相比,卵巢癌组织miR-515-5p的表达较低,CSPG4的表达较高(P<0.05)。与miR-NC组、miR-515-5p组相比,A2780细胞cyclinD1、MMP-2和MMP-9蛋白的表达较低,P21蛋白的表达较高,细胞活力较低,细胞迁移和侵袭数较少(P<0.05)。与si-NC组相比,si-CSPG4组A2780细胞cyclinD1、MMP-2和MMP-9蛋白的表达较低,P21蛋白的表达较高,细胞活力较低,细胞迁移和侵袭数较少(P<0.05)。与miR-515-5p+pcDNA组相比,miR-515-5p+pcDNA-CSPG4组A2780细胞cyclinD1、MMP-2和MMP-9蛋白的表达较高,P21蛋白的表达较低,细胞活力较高,细胞迁移和侵袭数较多(P<0.05)。MiR-515-5p靶向并负性调控CSPG4表达。   结论  MiR-515-5p通过靶向CSPG4可抑制卵巢癌细胞A2780增殖和转移。

Abstract

Objective  To investigate the targeted regulation of miR-515-5p on chondroitin sulfate proteoglycan 4 (CSPG4) and its effect on the proliferation and metastasis of ovarian cancer cell A2780.    Methods  The target genes of miR-515-5p were predicted by bioinformatics tools. Real-time PCR and Western blotting were used to detect the expression of miR-515-5p and CSPG4 in 65 cases ovarian cancer tissues and adjacent tissues. Ovarian cancer cells A2780 were divided into miR-NC group, miR-515-5p group, si-NC group, si-CSPG4 group, miR-515-5p + pcDNA group, miR-515-5p + pcDNA-CSPG4 group. MTT assay was used to detect cell proliferation. Transell was applied to detect cell migration and invasion, and Western blotting was selected to detect cyclinD1, P21, matrix metalloproteinase(MMP)-2 and MMP-9 protein expression. The double luciferase reporter gene experiment and Western blotting confirmed the regulation effect of miR-515-5p on CSPG4 gene.    Results  Bioinformatics analysis showed that CSPG4 was one of the potential target genes of miR-515-5p. Compared with the adjacent tissues, the expression of miR-515-5p was lower in ovarian cancer tissues, and the expression of CSPG4 was higher (P<0.05). Compared with the miR-NC group, the expression of cyclinD1, MMP-2 and MMP-9 protein was lower in A2780 cells of miR-515-5p group, the expression of P21 protein was higher, the cell viability was lower, and the number of cell migration and invasion was lower (P<0.05). Compared with the si-NC group, the expression of cyclinD1, MMP-2 and MMP-9 proteins were lower in A2780 cells in si-CSPG4 group, P21 protein was higher, cell viability was lower, and the number of cell migration and invasion was lower (P<0.05). Compared with the miR-515-5p + pcDNA group, the expression of cyclinD1, MMP-2 and MMP-9 proteins was higher in A2780 cells of miR-515-5p + pcDNA-CSPG4 group, the expression of P21 protein was lower, and the cell viability was higher, the number of cell   igration and invasion was higher (P<0.05). MiR-515-5p targeted and negatively regulated CSPG4 expression.    Conclusion  MiR-515-5p could inhibit the proliferation and metastasis of ovarian cancer cell A2780 by targeting CSPG4. 

关键词

卵巢癌 / 微小RAN-515-5p / 硫酸软骨素蛋白聚糖4 / 细胞增殖 / 转移 / Transwell实验 / 人 

Key words

Ovarian cancer / MicroRNA-515-5p / Chondroitin sucfac proteoglycan 4 / Cell proliferation / Metastasis / Transwell assays / Human

引用本文

导出引用
江红 黄艳丽 邢辉 汪黎明 郭红. MiR-515-5p通过调控硫酸软骨素蛋白聚糖4表达对卵巢癌A2780细胞增殖和转移的影响及其机制[J]. 解剖学报. 2022, 53(1): 42-49 https://doi.org/10.16098/j.issn.0529-1356.2022.01.006
JIANG Hong HUANG Yan-li XING Hui WANG Li-ming GUO Hong. Effects of miR-515-5p on the proliferation and metastasis of ovarian cancer cell A2780 by regulating the expression of chondroitin sulfate proteoglycan 4 and its mechanism[J]. Acta Anatomica Sinica. 2022, 53(1): 42-49 https://doi.org/10.16098/j.issn.0529-1356.2022.01.006
中图分类号: R737.31   

参考文献

1] Kroeger PT Jr, Drapkin R. Pathogenesis and heterogeneity of ovarian cancer[J]. Curr Opin Obstet Gynecol, 2017, 29(1): 26-34. 
[2] Siegel RL, Miller KD, Jemal A, et al. Cancer statistics, 2017[J]. CA Cancer J Clin, 2017, 67(1): 7-30. 
[3] Deb B, Uddin A, Chakraborty S. miRNAs and ovarian cancer: an overview[J]. J Cell Physiol, 2018, 233(5): 3846-3854. 
[4] Zhang X, Zhou J, Xue D, et al. MiR-515-5p acts as a tumor suppressor via targeting TRIP13 in prostate cancer[J]. Int J Biol Macromol, 2019, 129(1): 227-232. 
[5] Qiao K, Ning S, Wan L, et al. LINC00673 is activated by YY1 and promotes the proliferation of breast cancer cells via the miR-515-5p/MARK4/Hippo signaling pathway[J]. J Exp Clin Cancer Res, 2019, 38(1): 418. 
[6] Nicolosi PA, Dallatomasina A, Perris R. Theranostic impact of NG2/CSPG4 proteoglycan in cancer[J]. Theranostics, 2015, 5(5): 530-544. 
[7] Ye MH. CSPG4 promotes the proliferation and migration of epithelial ovarian cancer cells through c-Met and ERK1/2[D]. Hu’nan Hengyang: Nanhua University, 2018. (in Chinese) 
叶迈豪. CSPG4通过c-Met和ERK1/2促进上皮性卵巢癌细胞增殖与迁移的研究[D]. 湖南衡阳:南华大学, 2018.
[8] Suzuki HI, Katsura A, Matsuyama H, et al. MicroRNA regulons in tumor microenvironment[J]. Oncogene, 2015, 34(24): 3085-3094. 
[9] Gilam A, Edry L, Mamluk-Morag E, et al. Involvement of IGF-1R regulation by miR-515-5p modifies breast cancer risk among BRCA1 carriers[J]. Breast Cancer Res Treat, 2013, 138(3): 753-760. 
[10] Pardo OE, Castellano L, Munro CE, et al. miR-515-5p controls cancer cell migration through MARK4 regulation[J]. EMBO Rep, 2016, 17(4): 570-584. 
[11] Pinho FG, Frampton AE, Nunes J, et al. Downregulation of microRNA-515-5p by the estrogen receptor modulates sphingosine kinase 1 and breast cancer cell proliferation[J]. Cancer Res, 2013, 73(19): 5936-5948. 
[12] Zhang H, Wang X, Huang H, et al. Hsa_circ_0067997 promotes the progression of gastric cancer by inhibition of miR-515-5p and activation of X chromosome-linked inhibitor of apoptosis (XIAP)[J]. Artif Cells Nanomed Biotechnol, 2019, 47(1): 308-318. 
[13] Li J, Tang Z, Wang H, et al. CXCL6 promotes non-small cell lung cancer cell survival and metastasis via down-regulation of miR-515-5p[J]. Biomed Pharmacother, 2018, 97(1): 1182-1188. 
[14] Nicolosi PA, Dallatomasina A, Perris R. Theranostic impact of NG2/CSPG4 proteoglycan in cancer[J]. Theranostics, 2015, 5(5): 530-544. 
[15] Winship A, Van Sinderen M, Heffernan-Marks A, et al. Chondroitin sulfate proteoglycan protein is stimulated by interleukin 11 and promotes endometrial epithelial cancer cell proliferation and migration[J]. Int J Oncol, 2017, 50(3): 798-804. 
[16] Kang J, Li ZY, Chen L, et al. Research progress of CSPG4/NG2 in immunosuppressive therapy of glioma[J]. Chinese Journal of Minimally Invasive Neurosurgery, 2017, 22(1): 46-48. (in Chinese) 
康剑, 李宗阳, 陈垒, 等. CSPG4/NG2在胶质瘤免疫抑制治疗中的研究进展[J]. 中国微侵袭神经外科杂志, 2017, 22(1): 46-48.
[17] Chen Y. Expression of CSPG4 in epithelial ovarian cancer and its clinical significance[D]. Hu’nan Hengyang: Nanhua University, 2018. (in Chinese) 
陈嫣. CSPG4在上皮性卵巢癌组织中的表达及其临床意义[D]. 湖南衡阳:南华大学, 2018.
[18] Sun J. Expression of CSPG4 in pancreatic cancer and its correlation with prognosis[D]. Chongqing: Third Military Medical University, 2015.  (in Chinese) 
孙靖. CSPG4在胰腺癌中的表达及其与预后相关性的研究[D]. 重庆:第三军医大学, 2015.

基金

湖北省自然科学基金支持

PDF(11747 KB)

Accesses

Citation

Detail

段落导航
相关文章

/